At-The-Market Issuance Sales AgreementAt-the-Market Issuance Sales Agreement • August 9th, 2024 • Oragenics Inc • Pharmaceutical preparations • New York
Oragenics, Inc., a Florida corporation (the “Company”), confirms its agreement (this “Agreement”) with Ascendiant Capital Markets, LLC (the “Agent”), as follows:
